Health Canada — Medical Devices · Canada · 2018-11-02 · Type II
🏛Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Reported risk: Beckman Coulter has become aware of an increase in the sensitivity of the urobilinogen reaction via customer reports of falsely elevated (false positive) urobilinogen patient results for iChemVELOCITY urine chemistry strips. Affected strips are: lot numbers beginning with lot 7212143 Except for: 7212146, 7212148, 7212160, 7212162, 7212163 and 7212164. Patient results at the high end of the normal range for urobilinogen may be reported as abnormal (the first positive range) indicating an erroneous above normal result. This affects the 2 mg/dl reportable range (first abnormal range). As the worst case scenario, erroneous results released out of the lab may lead to additional minimally invasive work-up, including venipuncture resulting in temporary injury to the patient. This issue is not detected by quality control. There is no impact to the results of other analytes on the strip.
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.